Lv32
330 积分 2024-11-13 加入
Bruton tyrosine kinase inhibitors for multiple sclerosis
4天前
已完结
Discovery of NP3-253, a Potent Brain Penetrant Inhibitor of the NLRP3 Inflammasome
7天前
已完结
Discovery of Potent, Orally Bioavailable, Tricyclic NLRP3 Inhibitors
7天前
已完结
Discovery of clinical candidate GS8-164, a highly potent oral NLRP3 inflammasome inhibitor for inflammation disorders
10天前
已关闭
Multifaceted MRGPRX2: New insight into the role of mast cells in health and disease
19天前
已完结
A cereblon-based glue degrader of NEK7 regulates NLRP3 inflammasome in a context-dependent manner
21天前
已完结
PROTAC targeted protein degraders: the past is prologue
21天前
已完结
A cereblon-based glue degrader of NEK7 regulates NLRP3 inflammasome in a context-dependent manner
21天前
已完结
Early and long-term efficacy and safety of remibrutinib in patients with chronic spontaneous urticaria: 52-week data from the Phase 3 REMIX-1 and REMIX-2 studies
24天前
已完结
Focused update: Guidelines of care for the management of atopic dermatitis in adults
25天前
已完结
皖公网安备34019202002308
